Since liraglutide went off-patent last year, generics are on the way
Their clinical value lies not in any single endpoint, but in the capacity to concurrently address the cardiovascular, renal, and metabolic risk factors that commonly coexist in complex individuals
"Retatrutide Clinical Development: Safety and Efficacy in Phase 2 Trials." Clinical Endocrinology and Metabolism Review, 2024
But this is more useful: "Nausea felt strongest around dose day, worse after a larger dinner, and better on days when I drank more water and ate smaller protein-first meals." That is the difference between a symptom note and a GLP-1 pattern
By implementing these light protection strategies, the risk of photochemical degradation can be significantly reduced, helping to maintain the efficacy of semaglutide powder over time